Christine Dolan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Maravai Lifesciences Holdings, Inc. (MRVI)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Maravai Lifesciences Holdings, Inc. (MRVI) | Executive Vice President and General Manager, Cygnus | $450,966 | $1,454,198 |
| 2023 | Maravai Lifesciences Holdings, Inc. (MRVI) | General Manager, Cygnus Technologies | $455,444 | $2,263,082 |
| 2022 | Maravai Lifesciences Holdings, Inc. (MRVI) | General Manager, Cygnus Technologies | $436,557 | $1,594,953 |
| 2021 | Maravai Lifesciences Holdings, Inc. (MRVI) | General Manager, Cygnus Technologies | $411,887 | $844,670 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.